HUT71592A - Pharmaceutically active diketopiperazines - Google Patents

Pharmaceutically active diketopiperazines Download PDF

Info

Publication number
HUT71592A
HUT71592A HU9500436A HU9500436A HUT71592A HU T71592 A HUT71592 A HU T71592A HU 9500436 A HU9500436 A HU 9500436A HU 9500436 A HU9500436 A HU 9500436A HU T71592 A HUT71592 A HU T71592A
Authority
HU
Hungary
Prior art keywords
benzylidene
dioxopiperazine
compound
hydrogen
methoxybenzylidene
Prior art date
Application number
HU9500436A
Other languages
English (en)
Hungarian (hu)
Other versions
HU9500436D0 (en
Inventor
John Richardson Shaw
Christopher John Latham
Maria Ines Chicarelli-Robinson
Justin Stephen Bryans
Stephen James Brocchini
Mark Anthony David Collins
Original Assignee
Xenova Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenova Ltd filed Critical Xenova Ltd
Publication of HU9500436D0 publication Critical patent/HU9500436D0/hu
Publication of HUT71592A publication Critical patent/HUT71592A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU9500436A 1992-08-14 1993-08-16 Pharmaceutically active diketopiperazines HUT71592A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929217331A GB9217331D0 (en) 1992-08-14 1992-08-14 Pharmaceutical compounds

Publications (2)

Publication Number Publication Date
HU9500436D0 HU9500436D0 (en) 1995-04-28
HUT71592A true HUT71592A (en) 1996-01-29

Family

ID=10720385

Family Applications (2)

Application Number Title Priority Date Filing Date
HU9500436A HUT71592A (en) 1992-08-14 1993-08-16 Pharmaceutically active diketopiperazines
HU9500437A HUT71593A (en) 1992-08-14 1993-08-16 Diketopiperazines, pharmaceutical compositions containing and process for producing the compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
HU9500437A HUT71593A (en) 1992-08-14 1993-08-16 Diketopiperazines, pharmaceutical compositions containing and process for producing the compounds

Country Status (24)

Country Link
US (1) US5700804A (ko)
EP (2) EP0672036A1 (ko)
JP (2) JPH08504175A (ko)
KR (2) KR950702967A (ko)
AT (1) ATE162186T1 (ko)
AU (2) AU693420B2 (ko)
BG (2) BG99496A (ko)
BR (2) BR9306905A (ko)
CA (2) CA2141938A1 (ko)
CZ (2) CZ38195A3 (ko)
DE (1) DE69316370T2 (ko)
DK (1) DK0655060T3 (ko)
ES (1) ES2111169T3 (ko)
FI (2) FI950617A (ko)
GB (2) GB9217331D0 (ko)
GR (1) GR3026272T3 (ko)
HU (2) HUT71592A (ko)
IL (2) IL106695A0 (ko)
PL (2) PL307437A1 (ko)
RU (2) RU95108759A (ko)
SK (2) SK19495A3 (ko)
TW (1) TW334427B (ko)
WO (2) WO1994004512A1 (ko)
ZA (2) ZA935968B (ko)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9217331D0 (en) * 1992-08-14 1992-09-30 Xenova Ltd Pharmaceutical compounds
DK85193D0 (da) 1993-07-16 1993-07-16 Cancerforskningsfondet Af 1989 Suppression of inhibitors
GB9402805D0 (en) * 1994-02-14 1994-04-06 Xenova Ltd Pharmaceutical compounds
IL112627A0 (en) * 1994-02-14 1995-05-26 Xenova Ltd Diketopiperazines, their preparation and pharmaceutical or veterinary compositions containing them
GB9402809D0 (en) * 1994-02-14 1994-04-06 Xenova Ltd Pharmaceutical compounds
GB9402807D0 (en) * 1994-02-14 1994-04-06 Xenova Ltd Pharmaceutical compounds
GB9410387D0 (en) * 1994-05-24 1994-07-13 Xenova Ltd Pharmaceutical compounds
GB9426090D0 (en) * 1994-12-23 1995-02-22 Xenova Ltd Pharmaceutical compounds
GB9426071D0 (en) * 1994-12-23 1995-02-22 Xenova Ltd Pharmaceutical compounds
GB2310854B (en) * 1994-12-23 1998-09-09 Xenova Ltd Piperazine-2,5-dione derivatives as modulators of multi-drug resistance
GB9426224D0 (en) * 1994-12-23 1995-02-22 Xenova Ltd Pharmaceutical compounds
GB2311781B (en) * 1994-12-23 1998-09-16 Xenova Ltd Piperazine 2,5 dione derivatives as modulators of multi-drug resistance
US5891877A (en) * 1995-02-14 1999-04-06 Xenova Limited Pharmaceutical compounds
AU779230C (en) * 1999-12-03 2006-05-25 Emory University Curcumin analogues for treating cancer
US7288545B2 (en) * 2000-05-09 2007-10-30 Angiorx Corporation Piperazinedione compounds
US6635649B2 (en) * 2000-05-09 2003-10-21 Che-Ming Teng Piperazinedione compounds
CA2774959C (en) 2000-08-04 2016-05-31 Dmi Biosciences, Inc. Method of using diketopiperazines and composition containing them
ES2294026T3 (es) 2000-09-06 2008-04-01 Ap Pharma, Inc. Polimeros degradables de poliacetal.
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
US6815214B2 (en) * 2000-12-29 2004-11-09 Celltech R & D, Inc. Pharmaceutical uses and synthesis of diketopiperazines
GB2372740A (en) * 2001-01-17 2002-09-04 Xenova Ltd Diketopiperazines
CA2478522A1 (en) * 2002-03-08 2003-09-18 Emory University Novel curcuminoid-factor viia constructs as suppressors of tumor growth and angiogenesis
US7919497B2 (en) 2002-08-02 2011-04-05 Nereus Pharmaceuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
PT1529044E (pt) 2002-08-02 2008-01-14 Nereus Pharmaceuticals Inc Desidrofenila-histinas e os seus análogos e a síntese de desidrofenila-histinas e os seus análogos
US7935704B2 (en) 2003-08-01 2011-05-03 Nereus Pharmaceuticals, Inc. Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
DE10238144A1 (de) * 2002-08-15 2004-02-26 Basf Ag Verwendung von Diketopiperazin-Derivaten als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen
WO2004030522A2 (en) 2002-10-02 2004-04-15 Dmi Biosciences, Inc. Diagnosis and monitoring of diseases
CA2523467C (en) * 2003-05-15 2021-10-26 Dmi Biosciences, Inc. Treatment of t-cell mediated diseases
GB0314738D0 (en) 2003-06-24 2003-07-30 Glaxo Group Ltd Novel compounds
US7732605B2 (en) 2005-03-29 2010-06-08 Nereus Pharmaceuticals, Inc. Synthesis of diketopiperazines
US20070270464A1 (en) * 2006-02-24 2007-11-22 Emory University Prodrugs of curcumin analogs
US8129527B2 (en) 2006-11-03 2012-03-06 Nereus Pharmacuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
WO2009146320A1 (en) 2008-05-27 2009-12-03 Dmi Life Sciences, Inc. Therapeutic methods and compounds
WO2012033792A2 (en) 2010-09-07 2012-03-15 Dmi Acquisition Corp. Treatment of diseases
CA2826973C (en) * 2011-02-10 2020-03-24 Mannkind, Corp Formation of n-protected bis-3,6-(4-aminoalkyl)-2,5,diketopiperazine
MY172699A (en) 2011-10-10 2019-12-10 Ampio Pharmaceuticals Inc Implantable medical devices with increased immune tolerance, and methods for making and implanting
AU2012323305B2 (en) 2011-10-10 2017-07-27 Ampio Pharmaceuticals, Inc. Treatment of degenerative joint disease
AU2012328605B9 (en) 2011-10-28 2017-08-03 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
US9808454B2 (en) 2013-03-15 2017-11-07 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
CN103396372B (zh) * 2013-08-09 2015-05-20 中国科学院南海海洋研究所 一类2,5-二酮哌嗪衍生物及其制备方法和在制备抗海洋污损生物防除剂中的应用
CN105272968B (zh) * 2014-06-10 2018-03-13 首都医科大学 (3s,6r)‑3,6二取代哌嗪‑2,5‑二酮,其制备及应用
US9956217B2 (en) 2014-08-18 2018-05-01 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
CN104610170B (zh) * 2015-01-14 2017-02-01 中国科学院南海海洋研究所 2,5‑二酮哌嗪衍生物及其制备方法和应用
KR102623404B1 (ko) 2015-03-06 2024-01-11 비욘드스프링 파마수티컬스, 인코포레이티드. 뇌 종양 치료 방법
EP3265090A4 (en) 2015-03-06 2018-08-01 Beyondspring Pharmaceuticals Inc. Method of treating cancer associated with a ras mutation
WO2016209969A1 (en) 2015-06-22 2016-12-29 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases
EP3334726B1 (en) 2015-07-13 2022-03-16 Beyondspring Pharmaceuticals, Inc. Plinabulin compositions
MY192703A (en) 2016-02-08 2022-09-02 Beyondspring Pharmaceuticals Inc Compositions containing tucaresol or its analogs
MX2018015100A (es) 2016-06-06 2019-09-04 Beyondspring Pharmaceuticals Inc Composicion y metodo para reducir la neutropenia.
JP2020503363A (ja) 2017-01-06 2020-01-30 ビヨンドスプリング ファーマシューティカルズ，インコーポレイテッド チューブリン結合化合物およびその治療的使用
WO2018144764A1 (en) 2017-02-01 2018-08-09 Beyondspring Pharmaceuticals, Inc. Method of reducing neutropenia
CN110054619A (zh) * 2018-01-18 2019-07-26 西北农林科技大学 新型二酮哌嗪类组蛋白去乙酰化酶抑制剂
KR20200112881A (ko) 2018-01-24 2020-10-05 비욘드스프링 파마수티컬스, 인코포레이티드. 플리나불린의 투여를 통해 혈소판감소증을 감소시키는 조성물 및 방법
US11129878B1 (en) 2020-03-24 2021-09-28 Ampio Pharmaceuticals, Inc. Methods for treating diseases associated with respiratory viruses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE621862C (de) * 1932-07-01 1935-11-14 Guenther Schiemann Dr Verfahren zur Darstellung von Kondensationsprodukten kernfluorierter Arylaldehyde
BE584914A (ko) * 1958-11-24
JPS5747357A (en) * 1980-09-04 1982-03-18 Ricoh Co Ltd Novel disazo compound and its preparation
GB9217331D0 (en) * 1992-08-14 1992-09-30 Xenova Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
RU95108759A (ru) 1996-12-10
GB9217331D0 (en) 1992-09-30
ZA935969B (en) 1995-02-16
KR950702968A (ko) 1995-08-23
IL106695A0 (en) 1993-12-08
RU95108387A (ru) 1996-12-10
JPH08504176A (ja) 1996-05-07
SK19595A3 (en) 1995-09-13
FI950617A (fi) 1995-04-13
ES2111169T3 (es) 1998-03-01
ZA935968B (en) 1995-02-16
US5700804A (en) 1997-12-23
DE69316370D1 (de) 1998-02-19
AU693420B2 (en) 1998-07-02
BG99495A (en) 1995-12-29
EP0655060A1 (en) 1995-05-31
FI950616A0 (fi) 1995-02-13
WO1994004513A1 (en) 1994-03-03
EP0655060B1 (en) 1998-01-14
BG99496A (en) 1995-12-29
KR950702967A (ko) 1995-08-23
EP0672036A1 (en) 1995-09-20
CZ38395A3 (en) 1995-10-18
CZ38195A3 (en) 1995-09-13
PL307438A1 (en) 1995-05-29
CA2141939A1 (en) 1994-03-03
SK19495A3 (en) 1995-11-08
GR3026272T3 (en) 1998-06-30
AU4726593A (en) 1994-03-15
HU9500437D0 (en) 1995-04-28
BR9306904A (pt) 1998-12-08
GB2284420B (en) 1996-09-25
HU9500436D0 (en) 1995-04-28
IL106696A0 (en) 1993-12-08
TW334427B (en) 1998-06-21
AU678172B2 (en) 1997-05-22
DK0655060T3 (da) 1998-02-09
DE69316370T2 (de) 1998-07-16
BR9306905A (pt) 1998-12-08
CA2141938A1 (en) 1994-03-03
JPH08504175A (ja) 1996-05-07
FI950616A (fi) 1995-04-13
PL307437A1 (en) 1995-05-29
GB9502859D0 (en) 1995-04-05
ATE162186T1 (de) 1998-01-15
GB2284420A (en) 1995-06-07
FI950617A0 (fi) 1995-02-13
AU4726493A (en) 1994-03-15
WO1994004512A1 (en) 1994-03-03
HUT71593A (en) 1996-01-29

Similar Documents

Publication Publication Date Title
HUT71592A (en) Pharmaceutically active diketopiperazines
US5902812A (en) Pharmaceutical piperazine compounds
JP4199309B2 (ja) 新規アセトアミド誘導体およびプロテアーゼ阻害
JP2005521698A (ja) 新規な三環式化合物
US5852018A (en) Pharmaceutical piperazine compounds
CA3077245A1 (en) Lactam derivatives useful as inhibitors of mutant idh1
JP2004514669A (ja) セリンプロテアーゼ阻害剤として有用な酸誘導体
CN1139929A (zh) 取代的3-亚芳基-7-氮杂羟吲哚化合物及其制备方法
WO2020192650A1 (zh) 酰胺类化合物制备方法及其在医药领域的应用
CN111714628A (zh) 小分子pd-1/pd-l1抑制剂、其与pd-l1抗体的药物组合物及其应用
JP2016513103A (ja) アルビシジン誘導体、その使用および合成
JP7168245B2 (ja) 三環式化合物
KR20220020395A (ko) 삼환식 화합물, 이의 제조방법 및 용도
TW202239756A (zh) 作為組蛋白去乙醯酶6抑制劑之1,3,4-㗁二唑硫羰基化合物及包含該等化合物之醫藥組合物
WO2008025526A1 (en) Indole derivatives, their manufacture and use as pharmaceutical agents
WO2017148417A1 (zh) 一种2,3-环氧丁二酰衍生物及其制备方法和用途
WO2013106756A2 (en) Antimicrobial agents
CN112341377A (zh) 一种杂环类化合物及其应用
JP2003012667A (ja) キノリンカルボキサミド骨格を有する抗菌剤
JP2001514257A (ja) プロテアーゼ阻害剤
WO2017008681A1 (zh) 酰胺类衍生物、其制备方法及其在医药上的用途
WO2004046123A1 (en) Benzoxazole, benzthiazole and benzimidazole derivatives useful as heparanase inhibitors
JPH05246994A (ja) キノリルメトキシフエニル−アセトアミド類
JP2003238406A (ja) 医薬組成物
TWI853806B (zh) 小分子pd-1/pd-l1抑制劑、其與pd-l1抗體的藥物組合物及其應用

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee